Signal Advance Inc (SIGL) 0.0892 $SIGL Signal Advance,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Signal Advance Inc (SIGL) 0.0892 $SIGL

Signal Advance, Inc. enters Negotiations with OEM to utilize its Proprietary Technology to Improve Remote Power Systems Management
ACCESSWIRE - Thu Dec 17, 8:11AM CST
HOUSTON, TX / ACCESSWIRE / December 17, 2015 / Signal Advance, Inc. (OTC: SIGL), an emerging technology company, announces it is negotiating with an Original Equipment Manufacturer (OEM) to incorporate its proprietary Temporal Advance Signal Detection technology into current and future remote power system controls under development for a major oil and gas client. The development partner anticipates implementation of Signal Advance technology will improve remote power system management and enhance the efficiency of maintenance and operations thus generating savings.

Signal Advance to Focus its Patented Technology to Improve Efficiency, Performance and Safety on Automotive Vehicles
Marketwired - Thu Nov 12, 8:03AM CST
Signal Advance, Inc. (OTCBB: SIGL), an emerging technology company, has developed preliminary plans and initiated discussion with a University to utilize its proprietary technology to improve performance in signal detection and control systems in automotive vehicles. In transportation, Signal Advance technology applied to combustion/injector control has the potential to improve performance by reducing delay in the relevant control systems, and thereby generate more power using less fuel and releasing fewer emissions. The company anticipates its technology can also be applied to improve crash avoidance, deployment of air bags, driver assist and other safety measures.
HON: 115.76 (+0.80), ADI: 64.22 (+0.89)

Signal Advance Details Management Experience Applying Its Proprietary Technology in the Brain Health Market
Marketwired - Wed Jul 08, 6:00AM CDT
Signal Advance, Inc. (OTC PINK: SIGL) expounds on the credentials of the team members and catalysts behind its entry into the Brain Health market -- a nearly two billion dollar industry. The objective of Signal Advance Inc.'s enhanced Neural Training System project is to integrate auditory, visual, and direct current stimuli to the brain to improve brain function. Effective Neural Training relies on adjusting stimulator outputs in real-time based on measurements of the brain's response. Applying Signal Advance technology to offset the brain signal detection and processing delays is expected to reduce feedback delay and significantly improve training efficiency and efficacy.

The State Bar of Texas Intellectual Property Section Recognizes Dr. Chris M. Hymel, Signal Advance, Inc., as the 2015 Inventor of Year
Marketwired - Mon Jun 29, 6:00AM CDT
During the Annual Meeting of the State Bar of Texas the Intellectual Property Section named Chris M. Hymel, Ph.D., Signal Advance Inc. (OTC PINK: SIGL) Founder and President, the 2015 Inventor of the Year. The selection criteria included the intellectual property (patents), contribution of the invention to society and the impact on Texas economy. The award was presented on June 19, 2015, at the State Bar of Texas Annual Meeting, during the Intellectual Property Section luncheon meeting.

Signal Advance Founder Selected as the 2015 Inventor of Year by State Bar of Texas
Marketwired - Mon Jun 15, 6:00AM CDT
Signal Advance, Inc. (OTC PINK: SIGL) announced today that the Company's Founder, Chris M. Hymel, Ph.D., was named 2015 Inventor of the Year by the State Bar of Texas Intellectual Property Section. The award was based on his U.S. Patent 8,452,544, "Utility and method for the application of signal advance amplification to analog waveform or signal detection, acquisition and processing." This patent is the basis for the on-going development and commercialization of Signal Advance technology.

Signal Advance Announces Plans to Use Its Proprietary Technology in a Biotech Application
Marketwired - Wed Feb 04, 6:01AM CST
Signal Advance, Inc. (OTC PINK: SIGL) today announced plans to enter the nearly two billion dollar Neural Training market by applying its proprietary Signal Advance ("SA" technology to develop an enhanced Neural Training System. Neural Training (neuro-therapy, neuro-feedback) typically applies auditory, visual, or direct current stimuli to the brain to improve brain function. Effective Neural Training relies on quickly measuring the brain's response to stimuli and making real-time adjustments. In a University study, SA circuit designs were shown to reduce delays in measuring human bioelectric signals which should translate to faster detection of brain responses.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading